However, the antiviral capabilities of tumor cells are defective, and they may have defects in the PI3K/AKT signaling pathway or tumor suppressor genes such as P53 and RB127, which often makes tumor cells more sensitive to oncolytic viruses. This evidence concerns the gene AKT1 and neoplasm.